Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Cellular Injury IlI: Cellular Death01:11

Cellular Injury IlI: Cellular Death

Cell death is the irreversible loss of cellular structure and function, representing the final stage of severe injury. It plays a key role in both normal physiology and disease.Types of Cell DeathThe two main types are necrosis and apoptosis, though others like necroptosis and pyroptosis also exist.Necrosis:Necrosis is an unregulated form of cell death caused by severe injury such as trauma, toxins, or ischemia. It is characterized by cell swelling, membrane loss, rupture, and leakage of...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Impact of BECLIN1 haploinsufficiency on goblet cell function and susceptibility to colitis.

Cell death & disease·2026
Same author

Myeloid/lymphoid neoplasms with eosinophilia and ZMYM2::FLT3 fusion: clinical, pathological and molecular clues to a cryptic diagnosis.

Pathology·2026
Same author

Blood: flowing stronger than ever after 80 years.

Blood·2026
Same author

Retreatment with venetoclax and rituximab following disease progression while off therapy in patients with chronic lymphocytic leukemia.

HemaSphere·2025
Same author

Venetoclax and ibrutinib induces durable clinical responses in marginal zone lymphoma.

Blood advances·2025
Same author

A case of enterovirus D68-associated acute flaccid myelitis in an immunocompromised adult, Australia.

ASM case reports·2025

関連する実験動画

Updated: May 8, 2026

LPS and ATP-induced Death of PMA-differentiated THP-1 Macrophages and its Validation
06:12

LPS and ATP-induced Death of PMA-differentiated THP-1 Macrophages and its Validation

Published on: May 3, 2024

プログラムされた核細胞死によって,血小板の寿命が制限される.

Kylie D Mason1, Marina R Carpinelli, Jamie I Fletcher

  • 1Molecular Genetics of Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3050, Australia.

Cell
|March 27, 2007
PubMed
まとめ

血小板には,その寿命を制御する固有のアポトーシスプログラムがあります. Bcl-x(L) とBakのバランスは,分子時計のように働き,血小板数と機能に影響を与えます.

さらに関連する動画

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
05:49

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

関連する実験動画

Last Updated: May 8, 2026

LPS and ATP-induced Death of PMA-differentiated THP-1 Macrophages and its Validation
06:12

LPS and ATP-induced Death of PMA-differentiated THP-1 Macrophages and its Validation

Published on: May 3, 2024

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
05:49

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

科学分野:

  • 血液学 ヘマトロジ
  • 細胞生物学 細胞生物学
  • 分子生物学は分子生物学である.

背景:

  • 血小板は,血静と傷の修復に不可欠です.
  • 血小板の循環寿命の決定要因は,ほとんど不明のままである.
  • 血小板の生存は,血静的バランスを維持するために重要です.

研究 の 目的:

  • 血小板の寿命を左右する内在的なメカニズムを解明する.
  • 血小板の老化におけるアポトーシスの役割を調査する.
  • 血小板生存の分子調節体を特定するために.

主な方法:

  • ネズミの遺伝子操作 (遺伝子除去) を利用した.
  • 主要なタンパク質の薬理学的阻害を働かせました.
  • 血小板の半減期と in vivo の数値の定量化.
  • 血小板アポトーシスの経路を評価した.

主要な成果:

  • 血小板の生存は,固有のアポトーシスプログラムによって制御されます.
  • Bcl-x(L) タンパク質の分解により,老いた血小板が死亡する.
  • Bcl-x (L) の無活性化により,血小板の半減期が短縮され,血小板閉塞が起こります.
  • バックの削除は血小板の寿命を延ばし,Bcl-x (L) 欠乏症の欠陥を修正します.

結論:

  • 血小板は,アポトーシスを受けるように遺伝的にプログラムされています.
  • Bcl-x(L) /Bakバランスは,血小板寿命の分子時計として機能します.
  • この発見は,血小板疾患の理解と治療に重大な意味を持ちます.